Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Job ER, Bottazzi B, Gilbertson B, Edenborough KM, Brown LE, Mantovani A, Brooks AG, Reading PC.

PLoS One. 2013;8(3):e59623. doi: 10.1371/journal.pone.0059623. Epub 2013 Mar 27.

2.

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.

Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A.

J Immunol. 2008 Mar 1;180(5):3391-8.

3.

Interactions of influenza A virus with sialic acids present on porcine surfactant protein D.

van Eijk M, White MR, Batenburg JJ, Vaandrager AB, van Golde LM, Haagsman HP, Hartshorn KL.

Am J Respir Cell Mol Biol. 2004 Jun;30(6):871-9. Epub 2003 Dec 12.

PMID:
14672916
4.

Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.

Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, Mantovani A, Brooks AG, Reading PC.

J Immunol. 2010 Oct 1;185(7):4284-91. doi: 10.4049/jimmunol.1001613. Epub 2010 Sep 3.

5.

Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain.

van Eijk M, White MR, Crouch EC, Batenburg JJ, Vaandrager AB, Van Golde LM, Haagsman HP, Hartshorn KL.

J Immunol. 2003 Aug 1;171(3):1431-40.

6.

Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.

Andersen O, Vilsgaard Ravn K, Juul Sørensen I, Jonson G, Holm Nielsen E, Svehag SE.

Scand J Immunol. 1997 Oct;46(4):331-7.

7.

A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice.

Job ER, Bottazzi B, Short KR, Deng YM, Mantovani A, Brooks AG, Reading PC.

J Immunol. 2014 Jan 1;192(1):271-81. doi: 10.4049/jimmunol.1301814. Epub 2013 Dec 4.

8.

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.

Horváth A, Andersen I, Junker K, Lyck Fogh-Schultz B, Holm Nielsen E, Gizurarson S, Andersen O, Kármán J, Rajnavölgyi E, Erdei A, Svehag SE.

Antiviral Res. 2001 Oct;52(1):43-53.

PMID:
11530187
9.

Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor.

White MR, Crouch E, van Eijk M, Hartshorn M, Pemberton L, Tornoe I, Holmskov U, Hartshorn KL.

Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L831-40. Epub 2004 Dec 17.

10.
11.

Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.

Inforzato A, Peri G, Doni A, Garlanda C, Mantovani A, Bastone A, Carpentieri A, Amoresano A, Pucci P, Roos A, Daha MR, Vincenti S, Gallo G, Carminati P, De Santis R, Salvatori G.

Biochemistry. 2006 Sep 26;45(38):11540-51.

PMID:
16981714
12.

Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.

Kido H, Okumura Y, Yamada H, Le TQ, Yano M.

Curr Pharm Des. 2007;13(4):405-14. Review.

PMID:
17311557
13.

Role of Neuraminidase in Influenza A(H7N9) Virus Receptor Binding.

Benton DJ, Wharton SA, Martin SR, McCauley JW.

J Virol. 2017 May 12;91(11). pii: e02293-16. doi: 10.1128/JVI.02293-16. Print 2017 Jun 1.

14.

Glucosyl hesperidin prevents influenza a virus replication in vitro by inhibition of viral sialidase.

Saha RK, Takahashi T, Suzuki T.

Biol Pharm Bull. 2009 Jul;32(7):1188-92.

15.

Multiple components contribute to ability of saliva to inhibit influenza viruses.

White MR, Helmerhorst EJ, Ligtenberg A, Karpel M, Tecle T, Siqueira WL, Oppenheim FG, Hartshorn KL.

Oral Microbiol Immunol. 2009 Feb;24(1):18-24. doi: 10.1111/j.1399-302X.2008.00468.x.

16.
17.

Inhibition of influenza viral neuraminidase activity by collectins.

Tecle T, White MR, Crouch EC, Hartshorn KL.

Arch Virol. 2007;152(9):1731-42. Epub 2007 May 22.

PMID:
17514488
18.

Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.

Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger JK, Takahashi K, Jensenius JC, Thiel S, Hartshorn KL.

J Immunol. 2012 Sep 1;189(5):2478-87. doi: 10.4049/jimmunol.1103786. Epub 2012 Jul 30.

19.

Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.

Tecle T, White MR, Sorensen G, Gantz D, Kacak N, Holmskov U, Smith K, Crouch EC, Hartshorn KL.

Biochem J. 2008 Jun 1;412(2):323-9. doi: 10.1042/BJ20071663.

PMID:
18302538
20.

Influenza A virus entry into cells lacking sialylated N-glycans.

de Vries E, de Vries RP, Wienholts MJ, Floris CE, Jacobs MS, van den Heuvel A, Rottier PJ, de Haan CA.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7457-62. doi: 10.1073/pnas.1200987109. Epub 2012 Apr 23.

Supplemental Content

Support Center